12th Annual IBA World Life Sciences Conference

Memo

Subjects include: - Clinical trials: current trends and perspectives at a global level- Data exclusivity/Bolar - the EU Pharma Package and other jurisdictions- Antitrust and intellectual property - divisionals, patent settlements, unlawful PTEs and PTAs- Preventive health and longevity: legal perspectives shaping the future of healthcare- Cross-border intellectual property litigation- Integration of pharma and MedTech with hospitals, clinics and pharmacies- Liability and accountability in open science research- Combination products (drug-device) regulation: emerging legal complexities- Preparing for the entry into force of the WIPO GRATK Treaty- Artificial intelligence and biotechnology: rethinking patent standards- AI and data rights in life sciences and HealthTech deals (training data, model outputs and infringement risk)- Collaboration and licensing structures as financing tools- Life sciences M and A in uncertain markets - earnouts, contingent value rights, contingent milestones and intellectual property-driven valuation mechanics- Late-stage private financings and IPO alternatives (crossovers, structured preferred, PIPEs, ATMs, registered directs)- Cross-border investment constraints affecting financings and exits (CFIUS risk, sensitive health/genomic data and closing conditions) URLs:Tickets: https://go.evvnt.com/3479886-0?pid=5569Sponsor: https://go.evvnt.com/3479886-3?pid=5569 Prices:IBA Member: EUR 1305.00,Non-member: EUR 1520.00,Young lawyers (under 30 years): EUR 1520.00,Academics / judges (full-time): EUR 1520.00,Public lawyers: EUR 1520.00,Corporate Counsel: EUR 1520.00 Category: Conferences | Business and Economics | Legal Date and Time: 3rd June 2026 at 9:00 am to 5th June 2026 at 5:00 pm Venue details: Pestana Palace Lisboa, The Leading Hotels of the World, 54 Rua Jau, Lisboa, 1300-314, Portugal